264 related articles for article (PubMed ID: 31992335)
1. Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis.
Chaudhary P; Gibbs LD; Maji S; Lewis CM; Suzuki S; Vishwanatha JK
Breast Cancer Res; 2020 Jan; 22(1):11. PubMed ID: 31992335
[TBL] [Abstract][Full Text] [Related]
2. ANXA2 expression in African American triple-negative breast cancer patients.
Gibbs LD; Chaudhary P; Mansheim K; Hare RJ; Mantsch RA; Vishwanatha JK
Breast Cancer Res Treat; 2019 Feb; 174(1):113-120. PubMed ID: 30478786
[TBL] [Abstract][Full Text] [Related]
3. Exosomal Annexin II Promotes Angiogenesis and Breast Cancer Metastasis.
Maji S; Chaudhary P; Akopova I; Nguyen PM; Hare RJ; Gryczynski I; Vishwanatha JK
Mol Cancer Res; 2017 Jan; 15(1):93-105. PubMed ID: 27760843
[TBL] [Abstract][Full Text] [Related]
4. Important role of annexin A2 (ANXA2) in new blood vessel development in vivo and human triple negative breast cancer (TNBC) growth.
Sharma MC; Jain D
Exp Mol Pathol; 2020 Oct; 116():104523. PubMed ID: 32866522
[TBL] [Abstract][Full Text] [Related]
5. Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma.
Zhang HJ; Yao DF; Yao M; Huang H; Wu W; Yan MJ; Yan XD; Chen J
World J Gastroenterol; 2012 Nov; 18(41):5897-904. PubMed ID: 23139605
[TBL] [Abstract][Full Text] [Related]
6. [Exosomes derived from mesenchymal stem cells loaded with annexin A2 reduce the polarization of M2 macrophages to inhibit the growth of prostate cancer cells in nude mice].
Tian Y; Guo X; Cheng J; Wang P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Feb; 39(2):109-116. PubMed ID: 36872428
[TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of Annexin A2 Expression in Breast Cancer Patients.
Gibbs LD; Mansheim K; Maji S; Nandy R; Lewis CM; Vishwanatha JK; Chaudhary P
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33374917
[TBL] [Abstract][Full Text] [Related]
8. Annexin A2 (AnxA2) association with the clinicopathological data in different breast cancer subtypes: A possible role for AnxA2 in tumor heterogeneity and cancer progression.
Abdelraouf EM; Hussein RRS; Shaaban AH; El-Sherief HAM; Embaby AS; Abd El-Aleem SA
Life Sci; 2022 Nov; 308():120967. PubMed ID: 36116530
[TBL] [Abstract][Full Text] [Related]
9. Serum exosomal lncRNA XIST is a potential non-invasive biomarker to diagnose recurrence of triple-negative breast cancer.
Lan F; Zhang X; Li H; Yue X; Sun Q
J Cell Mol Med; 2021 Aug; 25(16):7602-7607. PubMed ID: 33949761
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer.
Gibbs LD; Vishwanatha JK
Oncotarget; 2018 Jan; 9(2):2697-2704. PubMed ID: 29416802
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HAND2-AS1 suppressed the growth of triple negative breast cancer via reducing secretion of MSCs derived exosomal miR-106a-5p.
Xing L; Tang X; Wu K; Huang X; Yi Y; Huan J
Aging (Albany NY); 2020 Dec; 13(1):424-436. PubMed ID: 33290256
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Annexin A2 as a novel diagnostic serum biomarker for lung cancer.
Yang J; Yang F; Nie J; Zou X; Tian H; Qin Y; Liu C
Cancer Biomark; 2015; 15(2):205-11. PubMed ID: 25519022
[TBL] [Abstract][Full Text] [Related]
13. Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.
O'Meara T; Safonov A; Casadevall D; Qing T; Silber A; Killelea B; Hatzis C; Pusztai L
Breast Cancer Res Treat; 2019 May; 175(1):247-259. PubMed ID: 30725384
[TBL] [Abstract][Full Text] [Related]
14. Combination of Small Extracellular Vesicle-Derived Annexin A2 Protein and mRNA as a Potential Predictive Biomarker for Chemotherapy Responsiveness in Aggressive Triple-Negative Breast Cancer.
Desai PP; Narra K; James JD; Jones HP; Tripathi AK; Vishwanatha JK
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612209
[TBL] [Abstract][Full Text] [Related]
15. ANXA2 (annexin A2) is crucial to ATG7-mediated autophagy, leading to tumor aggressiveness in triple-negative breast cancer cells.
Koh M; Lim H; Jin H; Kim M; Hong Y; Hwang YK; Woo Y; Kim ES; Kim SY; Kim KM; Lim HK; Jung J; Kang S; Park B; Lee HB; Han W; Lee MS; Moon A
Autophagy; 2024 Mar; 20(3):659-674. PubMed ID: 38290972
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma.
El-Abd N; Fawzy A; Elbaz T; Hamdy S
Tumour Biol; 2016 Jan; 37(1):211-6. PubMed ID: 26189841
[TBL] [Abstract][Full Text] [Related]
17. Exosomal LncRNA LINC00659 transferred from cancer-associated fibroblasts promotes colorectal cancer cell progression via miR-342-3p/ANXA2 axis.
Zhou L; Li J; Tang Y; Yang M
J Transl Med; 2021 Jan; 19(1):8. PubMed ID: 33407563
[TBL] [Abstract][Full Text] [Related]
18. Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT.
Zhu Y; Tao Z; Chen Y; Lin S; Zhu M; Ji W; Liu X; Li T; Hu X
Breast Cancer Res Treat; 2022 May; 193(1):65-81. PubMed ID: 35254603
[TBL] [Abstract][Full Text] [Related]
19. Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer.
Jiagge E; Jibril AS; Chitale D; Bensenhaver JM; Awuah B; Hoenerhoff M; Adjei E; Bekele M; Abebe E; Nathanson SD; Gyan K; Salem B; Oppong J; Aitpillah F; Kyei I; Bonsu EO; Proctor E; Merajver SD; Wicha M; Stark A; Newman LA
Ann Surg Oncol; 2016 Nov; 23(12):3843-3849. PubMed ID: 27469125
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of serum exosomal SUMO1P3 predicts unfavorable prognosis in triple negative breast cancer.
Na-Er A; Xu YY; Liu YH; Gan YJ
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):154-160. PubMed ID: 33506903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
